Optimal Clinical Target Volume of Radiotherapy Based on Microscopic Extension around the Primary Gross Tumor in Non-Small-Cell Lung Cancer: A Systematic Review
- PMID: 35565447
- PMCID: PMC9103011
- DOI: 10.3390/cancers14092318
Optimal Clinical Target Volume of Radiotherapy Based on Microscopic Extension around the Primary Gross Tumor in Non-Small-Cell Lung Cancer: A Systematic Review
Abstract
A crucial issue in radical radiation therapy for non-small-cell lung cancer is how to define the clinical target volume (CTV). Although the scope of microscopic extension (ME) and microscopic proximal bronchial extension (PBE) from a primary tumor should be considered when defining the CTV, there has been limited research on ME and PBE. Therefore, we conducted this systematic review. The PubMed, ICHUSHI (Japanese database), and Cochrane Library databases were searched, and 816 articles were initially retrieved. After primary and secondary screenings, eight articles were ultimately selected. The results of this systematic review suggest the importance of a 0 mm margin in stereotactic radiotherapy for early-stage cancer and a 5-8 mm margin in curative irradiation for locally advanced cancer. Regarding PBE, this review yielded the conclusion that it is appropriate to consider the addition of an approximately 15 mm margin from the bronchial vasculature. Although there were few articles with a high level of evidence, this systematic review enabled us to collate results from previous studies and to provide recommendations, to some extent, regarding the CTV margin in the current clinical environment, where high-precision radiation therapy, such as image-guided radiotherapy and intensity-modulated radiotherapy, is predominant.
Keywords: gross tumor volume; non-small-cell lung cancer; radiation therapy; systematic review.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- National Comprehensive Cancer Network NCCN Guidelines Version 3. 2019. Non-Small Cell Lung Cancer. [(accessed on 17 March 2019)]. Available online: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
-
- Giraud P., Antoine M., Larrouy A., Milleron B., Callard P., De Rycke Y., Carette M.F., Rosenwald J.C., Cosset J.M., Housset M., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:1015–1024. doi: 10.1016/S0360-3016(00)00750-1. - DOI - PubMed
-
- Grills I.S., Fitch D.L., Goldstein N.S., Yan D., Chmielewski G.W., Welsh R.J., Kestin L.L. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2007;69:334–341. doi: 10.1016/j.ijrobp.2007.03.023. - DOI - PubMed
-
- Stroom J., Blaauwgeers H., van Baardwijk A., Boersma L., Lebesque J., Theuws J., van Suylen R.J., Klomp H., Liesker K., van Pel R., et al. Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. Int. J. Radiat. Oncol. Biol. Phys. 2007;69:267–275. doi: 10.1016/j.ijrobp.2007.04.065. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
